Mydecine Innovations Group Announces Closing of First Tranche Under Share Subscription...

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical...

Silo Pharma Enters into Agreement with Contract Research Organization for Pharmacokinetic...

Numinus Completes First MDMA Administration in PTSD Trial Sponsored by MAPS

atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial...

Albert Labs Files US Provisional Patent Application and Proves Out Consistent...

PT305 – Emma Farrell – Plant Spirits, Entities, and Remembering Lost...

MindMed Reports Full Year 2021 Financial Results and Business Highlights

MindMed Announces Transition of CFO

Mydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study

Load more